Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

853
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
853
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

802
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
802
Antibiotic Selection00:57

Antibiotic Selection

58.1K
Overview
58.1K
Stringent Response in E. coli01:23

Stringent Response in E. coli

182
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
182
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

108
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
108

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to White and Siegrist, "Multi-drug-resistant enterococcal infections: duration of combination therapy and OPAT challenges".

Antimicrobial agents and chemotherapy·2026
Same author

Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Loss of the ferripyochelin receptor FptA drives reduced cefiderocol susceptibility and impairs fitness in <i>Pseudomonas aeruginosa</i> PA14.

Antimicrobial agents and chemotherapy·2026
Same author

Utilization of Intensive Care Interventions in Critically Ill Patients With Candidemia Versus Bacteremia: A Multicenter Retrospective Cohort Study.

Critical care medicine·2026
Same author

Current Management of Serious Infections due to Vancomycin-resistant Enterococci.

Infectious disease clinics of North America·2026
Same author

Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD.

Blood advances·2026
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Dec 2, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.5K

Resistance in Vancomycin-Resistant Enterococci.

William R Miller1, Barbara E Murray2, Louis B Rice3

  • 1Department of Internal Medicine, Division of Infectious Diseases, University of Texas Health Science Center at Houston, McGovern Medical School, 6431 Fannin St. MSB 2.112, Houston, TX 77030, USA; Center for Antimicrobial Resistance and Microbial Genomics (CARMiG).

Infectious Disease Clinics of North America
|November 2, 2020
PubMed
Summary
This summary is machine-generated.

Serious infections from vancomycin-resistant enterococci (VRE) remain challenging despite new antibiotics. Understanding resistance emergence and colonization is key for better clinical management of these difficult hospital-associated pathogens.

Keywords:
Colonization resistanceMechanisms of resistanceVREVRE colonizationVancomycin resistant enterococcus

More Related Videos

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

25.8K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.7K

Related Experiment Videos

Last Updated: Dec 2, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.5K
One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

25.8K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.7K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Serious infections caused by vancomycin-resistant enterococci (VRE) present significant clinical challenges.
  • Treatment often requires combination therapy and careful management of toxicity.
  • Despite new antibiotic options, VRE infections remain difficult to treat.

Purpose of the Study:

  • To highlight the persistent challenges in managing vancomycin-resistant enterococci infections.
  • To emphasize the need for a deeper understanding of VRE resistance and colonization.
  • To prepare clinicians for tackling these hospital-associated pathogens more effectively.

Main Methods:

  • Review of current literature on vancomycin-resistant enterococci.
  • Analysis of factors contributing to resistance emergence.
  • Examination of gastrointestinal colonization dynamics and microbiota-mediated resistance.
  • Investigation of resistance mechanisms against available therapeutics.

Main Results:

  • Vancomycin-resistant enterococci infections continue to be a major clinical concern.
  • New antibiotics have been introduced, but significant therapeutic challenges persist.
  • Understanding resistance drivers and colonization is crucial for effective treatment.

Conclusions:

  • A comprehensive understanding of VRE resistance mechanisms and colonization is essential.
  • This knowledge will better equip clinicians to manage VRE infections.
  • Improved preparedness is vital for combating these challenging hospital-associated pathogens.